Go-6976 reverses hyperglycemia-induced insulin resistance independently of cPKC inhibition in adipocytes
Go-6976 reverses hyperglycemia-induced insulin resistance independently of cPKC inhibition in adipocytes
Chronic hyperglycemia induces insulin resistance by mechanisms that are incompletely understood. One model of hyperglycemia-induced insulin resistance involves chronic preincubation of adipocytes in the presence of high glucose and low insulin concentrations. We have previously shown that the mTOR complex 1 (mTORC1) plays a partial role in the development of insulin resistance in this model. Here, we demonstrate that treatment with Go-6976, a widely used "specific" inhibitor of cPKCs, alleviates hyperglycemia-induced insulin resistance. However, the effects of mTOR inhibitor, rapamycin and Go-6976 were not additive and only rapamycin restored impaired insulin-stimulated AKT activation. Although, PKCα, (but not -β) was abundantly expressed in these adipocytes, our studies indicate cPKCs do not play a major role in causing insulin-resistance in this model. There was no evidence of changes in the expression or phosphorylation of PKCα, and PKCα knock-down did not prevent the reduction of insulin-stimulated glucose transport. This was also consistent with lack of IRS-1 phosphorylation on Ser-24 in hyperglycemia-induced insulin-resistant adipocytes. Treatment with Go-6976 did inhibit a component of the mTORC1 pathway, as evidenced by decreased phosphorylation of S6 ribosomal protein. Raptor knock-down enhanced the effect of insulin on glucose transport in insulin resistant adipocytes. Go-6976 had the same effect in control cells, but was ineffective in cells with Raptor knock-down. Taken together these findings suggest that Go-6976 exerts its effect in alleviating hyperglycemia-induced insulin-resistance independently of cPKC inhibition and may target components of the mTORC1 signaling pathway.
Robinson, Katherine A.
5cc32ce8-e130-47f1-afe3-e8253381583c
Hegyi, Krisztina
ba174082-24e9-4b49-abec-b35f68269a79
Hannun, Yusuf A.
b89a0b1f-006e-4e76-947e-de213df9d2f9
Buse, Maria G.
2c7d89f7-3ea6-4ffc-a856-06ac5b9d42d5
Sethi, Jaswinder K.
923f1a81-91e4-46cd-8853-bb4a979f5a85
15 October 2014
Robinson, Katherine A.
5cc32ce8-e130-47f1-afe3-e8253381583c
Hegyi, Krisztina
ba174082-24e9-4b49-abec-b35f68269a79
Hannun, Yusuf A.
b89a0b1f-006e-4e76-947e-de213df9d2f9
Buse, Maria G.
2c7d89f7-3ea6-4ffc-a856-06ac5b9d42d5
Sethi, Jaswinder K.
923f1a81-91e4-46cd-8853-bb4a979f5a85
Robinson, Katherine A., Hegyi, Krisztina, Hannun, Yusuf A., Buse, Maria G. and Sethi, Jaswinder K.
(2014)
Go-6976 reverses hyperglycemia-induced insulin resistance independently of cPKC inhibition in adipocytes.
PLoS ONE, 9 (10), [A1306].
(doi:10.1371/journal.pone.0108963).
Abstract
Chronic hyperglycemia induces insulin resistance by mechanisms that are incompletely understood. One model of hyperglycemia-induced insulin resistance involves chronic preincubation of adipocytes in the presence of high glucose and low insulin concentrations. We have previously shown that the mTOR complex 1 (mTORC1) plays a partial role in the development of insulin resistance in this model. Here, we demonstrate that treatment with Go-6976, a widely used "specific" inhibitor of cPKCs, alleviates hyperglycemia-induced insulin resistance. However, the effects of mTOR inhibitor, rapamycin and Go-6976 were not additive and only rapamycin restored impaired insulin-stimulated AKT activation. Although, PKCα, (but not -β) was abundantly expressed in these adipocytes, our studies indicate cPKCs do not play a major role in causing insulin-resistance in this model. There was no evidence of changes in the expression or phosphorylation of PKCα, and PKCα knock-down did not prevent the reduction of insulin-stimulated glucose transport. This was also consistent with lack of IRS-1 phosphorylation on Ser-24 in hyperglycemia-induced insulin-resistant adipocytes. Treatment with Go-6976 did inhibit a component of the mTORC1 pathway, as evidenced by decreased phosphorylation of S6 ribosomal protein. Raptor knock-down enhanced the effect of insulin on glucose transport in insulin resistant adipocytes. Go-6976 had the same effect in control cells, but was ineffective in cells with Raptor knock-down. Taken together these findings suggest that Go-6976 exerts its effect in alleviating hyperglycemia-induced insulin-resistance independently of cPKC inhibition and may target components of the mTORC1 signaling pathway.
This record has no associated files available for download.
More information
Accepted/In Press date: 5 September 2014
e-pub ahead of print date: 15 October 2014
Published date: 15 October 2014
Identifiers
Local EPrints ID: 415249
URI: http://eprints.soton.ac.uk/id/eprint/415249
ISSN: 1932-6203
PURE UUID: 4f6b2263-017e-4d9e-8deb-4048420ea1ae
Catalogue record
Date deposited: 06 Nov 2017 17:30
Last modified: 06 Jun 2024 01:59
Export record
Altmetrics
Contributors
Author:
Katherine A. Robinson
Author:
Krisztina Hegyi
Author:
Yusuf A. Hannun
Author:
Maria G. Buse
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics